In mouse glioma models, high-mobility group box 1 (HMGB1), an alarmin produced by dying cancer cells, activates TLR2 in dendritic cells (DCs) and leads to brain tumor regression [110]. This evidence concerns the gene HMGB1 and central nervous system cancer.